|
Basic InformationMore InformationLatest NewsHIV No Barrier to Getting Liver Transplant, Study FindsImmune Cell Discovery May One Day Lead to Herpes Vaccine: StudyHalf of People With Hepatitis C Don't Complete Needed Tests: CDCNew Guidelines Suggest HIV Screening for All AdultsHIV 'Cure' Looks 'Promising,' Danish Scientists ContendSofosbuvir Shows Promise for Chronic Hepatitis C InfectionStudy Hints of Links Between HPV and Lung CancerCould Self-Testing Help Overcome HIV/AIDS Epidemic?Experimental Drug May Work Against Hepatitis CHIV Prevalence Is High Among High-Risk HeterosexualsCDC: 1 in 50 Poor, Straight Urban Americans Infected With HIVHIV Infection Linked to Risk of Acute Myocardial InfarctionHIV May Raise Risk of Heart AttackResearchers Describe 1st 'Functional Cure' of HIV in BabyU.S. AIDS-Relief Plan a Success, Report FindsMillions of Americans Have an STD: ReportCertain Skin Cancers More Common in HIV-Positive PeopleDrug Users Are 'Super-Spreaders' of Hepatitis C, Study FindsStudy Pinpoints Optimal Treatment Window for HIVGeneric Three-Pill HIV Regimen Could Result in Big SavingsSome HPV-Linked Cancers Rising in U.S.: ReportNew Pills Show Promise for Hepatitis CFulyzaq Approved for Diarrhea in People With HIV/AIDSHepatitis: The Hidden HazardSmoking Deadlier For HIV Patients Than Virus Itself: StudyKids With HIV at Risk of Heart Disease, Study SaysUse of Clinical Decision-Support System Can Improve HIV CareAmong Black Americans, HIV Takes a Greater TollNew HIV Infections Highest Among Urban Gay, Bisexual Men: CDCHIV Infections Continue to Hit Young Americans HardAIDS Deaths, New HIV Infections Continue to Drop WorldwideU.S. Task Force Backs HIV Screening for All 15 to 65Antiviral Therapy for Hepatitis C May Thwart Liver CancerHigh-Dose Vitamins Don't Halt HIV Progression, DeathExperimental Vaccine Might Help Women Already Infected With HPVMore Stomach, Esophageal Cancers Seen in AIDS Patients Than OthersScientists Probe How Some HIV Patients Resist AIDSImproved HIV Care Boosts Life Expectancy at Clinic, Study FoundAntiretrovirals Increasingly Used for HIV in the U.S.More Americans Get Effective HIV Treatment, Study SaysOnce-Daily Pill Approved to Treat HIVHepatitis C Treatment May Hamper Kids' GrowthGonorrhea Resistant to All But One Antibiotic: CDCNew Clues to How HIV Infects Body's CellsOnly 1 in 4 Americans With HIV Has Virus Under Control: CDCHIV Drug-Resistance Up in Resource-Limited SettingsAll HIV Patients Should Take Meds Early On, Experts Now SayMom's HIV Drugs May Pass to Baby in Womb, Breast-FeedingNot All HIV Patients in U.S. Show Same Characteristics: StudyHIV Racial Disparities Noted for Men Who Have Sex With Men Questions and AnswersLinksBook Reviews |
| |
Young Men Taking HIV Meds May Be at Risk for Bone Loss
by -- Robert Preidt
Updated: Jun 22nd 2012
FRIDAY, June 22 (HealthDay News) -- Young men receiving drug treatment for HIV infection are at increased risk for low bone mass, a new study suggests.
The findings indicate that these patients should exercise, take vitamin D and be closely monitored in order to reduce their future risk of bone fractures, according to the study, released online in advance of print publication in the journal Clinical Infectious Diseases.
The study included about 250 male participants, aged 14 to 25, who underwent whole-body scans to measure their bone density. Some of the men were infected with HIV, the virus that causes AIDS.
The participants with HIV had been diagnosed with the infection an average of two years earlier. The HIV-infected males had an average 5 percent to 8 percent lower bone density in the hip and 2 percent to 4 percent lower bone density in the spine than those without HIV.
Although the study uncovered an association between treatment for HIV infection and lower bone density in the study participants, it did not prove a cause-and-effect relationship.
The study, funded by the U.S. National Institute of Child Health and Human Development (NICHD), did not look at the causes of bone loss and cannot rule out the possibility that low bone mass was present before HIV infection.
The investigators noted that all the participants had several risk factors for bone loss, including tobacco and alcohol use and low intake of calcium and vitamin D, which is needed to absorb calcium.
"The young [HIV-positive] men in the study had been taking anti-HIV medications for a comparatively short time, yet they still had lower bone-mineral density than other men their age," study co-author Dr. Bill Kapogiannis, of the pediatric, adolescent and maternal AIDS branch of the NICHD, said in an institute news release.
"These findings suggest a short-term impact of HIV therapy on bone at ages when people are still growing and building bone mass," Kapogiannis added. "This raises concerns about the risk of fracture as they age."
Previous research in adults has indicated that there may be an association between the use of certain anti-HIV medications and an increased risk for bone fractures and bone loss, the study authors noted in the news release.
Doctors who care for young men with HIV should monitor these patients regularly for signs of bone thinning, which could predict a risk for fractures, the researchers said. Young men newly diagnosed with HIV also should exercise, quit smoking, limit alcohol consumption and get the proper amount of calcium and vitamin D.
More information
The New Mexico AIDS Education and Training Center outlines the side effects of anti-HIV drugs.
This article: Copyright © 2012 HealthDay. All rights reserved. |
